PlGF and Flt-1 Ratio: A New Tool for Cardiovascular Risk Assessment
The invention uses the significance of the biochemical markers PlGF and Flt-1 for risk stratification of people with a cardiovascular disease. The method involves the quantification and calculation of the ratio of PlGF / Flt-1 in a sample derived from the patient by means of a diagnostic kit.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/798-49721
Contact
Dr. Otmar Schöller
